REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Recruiting · NCT07160231 · Registry updated 2025-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases | Axial Spondyloarthritis, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, rheumatic disorder, rheumatoid arthritis, skin disorder, spondylitis, vertebral column disorder | Recruiting | Phase 4 | 2025-09-17 | NCT07160231 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sint Maartenskliniek | 9 |
| ZonMw: The Netherlands Organisation for Health Research and Development | 103 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Elisabeth-TweeSteden Ziekenhuis Tilburg | Tilburg | Netherlands | 2 |
| Erasmus MC | Rotterdam | Netherlands | 22 |
| Isala Zwolle | Zwolle | Netherlands | 3 |
| Maasstad Ziekenhuis | Rotterdam | Netherlands | 3 |
| Maastricht UMC+ | Maastricht | Netherlands | 13 |
| Medisch Spectrum Twente | Enschede | Netherlands | 6 |
| Sint Maartenskliniek Nijmegen | Nijmegen | Netherlands | 1 |